Company profile for Dyadic International, Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Dyadic International, Inc. (OTCQX: DYAI) - We are a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help bring biologic vaccines and drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers to improve access and cost to patients and the healthcare system - but most importantly to save liv...
Dyadic International, Inc. (OTCQX: DYAI) - We are a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help bring biologic vaccines and drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers to improve access and cost to patients and the healthcare system - but most importantly to save lives.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
140 Intracoastal Pointe Drive, Suite 404, Jupiter, FL 33477-5094
Telephone
Telephone
561 743 8333
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/29/3176304/0/en/Dyadic-to-Report-Third-Quarter-2025-Financial-Results-on-Wednesday-November-12-2025.html

GLOBENEWSWIRE
29 Oct 2025

https://www.globenewswire.com/news-release/2025/10/06/3161717/0/en/Dyadic-Applied-BioSolutions-Announces-Milestone-Achievements-and-Recent-Company-Developments.html

GLOBENEWSWIRE
06 Oct 2025

https://www.globenewswire.com/news-release/2025/09/04/3144602/0/en/Dyadic-to-Present-at-Investor-Conferences-and-BPI-East.html

GLOBENEWSWIRE
04 Sep 2025

https://www.globenewswire.com/news-release/2025/08/13/3132946/0/en/Dyadic-Reports-Second-Quarter-2025-Financial-Results-and-Highlights-of-Recent-Company-Progress.html

GLOBENEWSWIRE
13 Aug 2025

https://www.globenewswire.com/news-release/2025/08/05/3127857/0/en/Dyadic-to-Report-Second-Quarter-2025-Financial-Results-on-Wednesday-August-13-2025.html

GLOBENEWSWIRE
05 Aug 2025

https://www.globenewswire.com/news-release/2025/07/31/3125026/0/en/UPDATE-Dyadic-International-Inc-Announces-Pricing-of-Public-Offering-of-6-052-000-Shares-of-Common-Stock.html

GLOBENEWSWIRE
31 Jul 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty